Gürbüz, A.F.; Koçak, M.Z.; Yıldız, O.; Genç, Ö.; Kaya, B.E.; Aykut, T.; Eryılmaz, M.K.; Araz, M.; Artaç, M.
Prognostic Value of C-Reactive Protein–Albumin–Lymphocyte (CALLY) Index for Survival in Nivolumab-Treated Metastatic Renal Cell Carcinoma. Medicina 2026, 62, 1009.
https://doi.org/10.3390/medicina62061009
AMA Style
Gürbüz AF, Koçak MZ, Yıldız O, Genç Ö, Kaya BE, Aykut T, Eryılmaz MK, Araz M, Artaç M.
Prognostic Value of C-Reactive Protein–Albumin–Lymphocyte (CALLY) Index for Survival in Nivolumab-Treated Metastatic Renal Cell Carcinoma. Medicina. 2026; 62(6):1009.
https://doi.org/10.3390/medicina62061009
Chicago/Turabian Style
Gürbüz, Ali Fuat, Mehmet Zahid Koçak, Oğuzhan Yıldız, Ömer Genç, Bahattin Engin Kaya, Talat Aykut, Melek Karakurt Eryılmaz, Murat Araz, and Mehmet Artaç.
2026. "Prognostic Value of C-Reactive Protein–Albumin–Lymphocyte (CALLY) Index for Survival in Nivolumab-Treated Metastatic Renal Cell Carcinoma" Medicina 62, no. 6: 1009.
https://doi.org/10.3390/medicina62061009
APA Style
Gürbüz, A. F., Koçak, M. Z., Yıldız, O., Genç, Ö., Kaya, B. E., Aykut, T., Eryılmaz, M. K., Araz, M., & Artaç, M.
(2026). Prognostic Value of C-Reactive Protein–Albumin–Lymphocyte (CALLY) Index for Survival in Nivolumab-Treated Metastatic Renal Cell Carcinoma. Medicina, 62(6), 1009.
https://doi.org/10.3390/medicina62061009
